Article
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
Current hematologic malignancy reports - 1 Oct 2023
Yuan Ji, He Rong, Alkhateeb Hassan B
Abstract excerpt
PURPOSE OF REVIEW: CCAAT enhancer binding protein A (CEBPA) gene mutation is one of the common genetic alterations in acute myeloid leukemia (AML), which can be associated with sporadic and familial AML. RECENT FINDINGS: Due to the recent advances in molecular testing and the prognostic role of CEBPA mutation in AML, the definition for AML with CEBPA mutation (AML-CEBPA) has significantly changed. This review...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
